Trevi Therapeutics, Inc. TRVI Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s retained earnings?
- Trevi Therapeutics, Inc. (TRVI) reported retained earnings of -$343M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s retained earnings changed year-over-year?
- Trevi Therapeutics, Inc.'s retained earnings decreased by 15.3% year-over-year, from -$297.39M to -$343M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s retained earnings has grown at a 17.5% compound annual growth rate (CAGR), from -$146.98M to -$329.8M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.